BioVantra
  • Home
  • About
  • Services04
    01 Integrated Prostate Cytomolecular Testing Integrated cytologic and molecular information in a structured, clinically useful report. 02 Prostate Cancer Estimation and Mapping Structured interpretation of cancer extent, lesion distribution, and treatment relevance. 03 Integrated Urothelial Cytomolecular Testing Non-invasive cytology and molecular analysis to support bladder cancer detection and surveillance. 04 Digital Pathology and Reporting Support Digital pathology and synoptic reporting support for clarity and consistency.
    Full service catalogue View all services →
  • Resources
  • Contact
Client Portal Request Information →
  • Home
  • About
    • All services
    • Diagnostic services
    • Integrated Prostate Cytomolecular Testing
    • Integrated Urothelial Cytomolecular Testing
    • Prostate Cancer Estimation and Mapping
    • Digital Pathology and Reporting Support
  • Resources
  • Contact
Client Portal Request Information →
Legal · Disclaimer

Website / Medical Disclaimer

Content on biovantra.com is provided for general informational use by clinicians and other professional audiences and is not a substitute for clinical judgment or the care of a treating physician.

Effective: May 11, 2026 · Last updated: May 11, 2026

1. Informational use only

Information on this website — including descriptions of BioVantra's clinical laboratory services (such as Integrated Prostate Cytomolecular Testing, Integrated Urothelial Cytomolecular Testing, Prostate Cancer Estimation and Mapping, and Digital Pathology and Reporting Support), reference materials, downloadable PDFs, and supporting literature — is provided for general informational purposes. It is intended primarily for clinicians, healthcare organizations, and other professional audiences. It is not intended to provide medical advice and should not be relied upon as such.

2. No physician-patient relationship

Visiting biovantra.com, downloading materials, contacting BioVantra by email or phone, or otherwise interacting with the site does not create a physician-patient, healthcare provider-patient, laboratorian-patient, or other clinical relationship between BioVantra (or any individual associated with BioVantra) and any user. Patients should not rely on this site for medical advice and should consult their own physicians regarding any medical condition, symptom, diagnosis, or treatment decision.

3. Clinical decision-making remains with the treating physician

BioVantra's diagnostic services are designed to provide structured, integrated information for use by ordering clinicians and multidisciplinary teams. Diagnostic, therapeutic, and treatment-planning decisions remain the responsibility of the treating physician and the broader care team. BioVantra's reports are intended to complement — not replace — clinical evaluation, imaging, histopathology, biopsy, multidisciplinary review, and individual physician judgment.

4. AI-assisted tools are decision-support

Where this site describes AI-enhanced, AI-assisted, or computer-aided workflow components — for example, AI-enhanced mpMRI lesion analysis or AI-assisted digital pathology workflow tools — those components are described as decision-support that informs the integrated report. They are not described as autonomous diagnosis, and they are not represented as replacing the judgment of physicians, pathologists, or other qualified clinicians.

5. No guaranteed outcome

Nothing on this site constitutes a guarantee of diagnostic accuracy, detection sensitivity or specificity, treatment outcome, cure, eligibility for a particular treatment, or payer coverage or reimbursement for any service. Service descriptions are general summaries and do not establish performance commitments.

6. CAP accreditation and CLIA certification

BioVantra is identified on this site as CAP-accredited and CLIA-certified (CAP 7214934 · CLIA 10D1087213). Accreditation and certification refer to laboratory quality and regulatory standards. They do not certify the clinical outcome of any particular case, do not constitute endorsement of any specific service or product, and do not substitute for clinical evaluation or treatment by qualified physicians.

7. Third-party references

Citations to peer-reviewed literature on this site are provided as supporting clinical reference. They are not exhaustive, are not endorsements of any specific therapy or product, and may not reflect the most current literature on a given topic. References to third-party products or tools (for example, the Lumea BxLink Client Portal, or AI-assisted prostate MRI lesion analysis tools) are descriptive only and do not imply endorsement by or affiliation with those vendors except as expressly stated.

8. External links

The site may link to external websites for convenience. BioVantra does not control and is not responsible for the content or availability of those sites and does not endorse them by virtue of providing a link.

9. Forward-looking statements

Where this site describes future-oriented plans, capabilities, or workflow integrations, those descriptions are aspirational rather than commitments. Capabilities, services, and reporting structures may change without notice.

10. Emergency and urgent clinical situations

This site is not designed to support emergencies. If you are experiencing a medical emergency, call 911 or your local emergency number, or go to the nearest emergency department. Do not use email, the contact page, or the Lumea BxLink Client Portal for urgent clinical communication.

11. Contact

Questions about this disclaimer can be sent to contact@biovantra.com.

BioVantra

Integrated urologic diagnostics — cytomolecular testing, cancer estimation and mapping, and digital pathology and reporting support for urologists and other healthcare professionals involved in the diagnosis, surveillance, and treatment planning of prostate and bladder cancer.

Company
Home About Contact
Services
Integrated Prostate Cytomolecular Testing Prostate Cancer Estimation & Mapping Integrated Urothelial Cytomolecular Testing Digital Pathology & Reporting Support
For clients
Resources Client Portal Support / Contact
Email contact@biovantra.com
Phone (352) 861-2296 Fax (352) 671-2737
Office 9401 SW Highway 200, STE 502
Ocala, FL 34481-9650
Quality CAP Accredited · 7214934 CLIA Certified · 10D1087213
© 2026 BioVantra. All rights reserved.
Privacy Terms HIPAA Notice Disclaimer Electronic Communications Accessibility Nondiscrimination